Category: Drugs

  • Computerized Provider Order Entry Against Drug Errors

    Computerized Provider Order Entry Against Drug Errors Table of Contents Example of Computerized Provider Order Entry Personal Experience Conclusion References The introduction of information technology in nursing practice is a natural stage in the development of the healthcare sector. The use of the possibilities of technical progress in the care environment is welcomed, and certain…

  • The Problem of Increased Morbidity From Adverse Drug Events in Older Adults

    The Problem of Increased Morbidity From Adverse Drug Events in Older Adults In my project, I plan to address the problem of increased morbidity from adverse drug events in older adults. Currently, adverse drug events are a considerable bother of US healthcare, as it is associated with increased morbidity and mortality, longer hospital stays, and…

  • E-Prescribing Drug Technology in the Healthcare

    E-Prescribing Drug Technology in the Healthcare Table of Contents Technology Description Patient Benefits and Safety Resistance to Change Communicating and Implementing Change Measuring Impact Conclusion References Drug prescriptions are one of the most complex healthcare delivery aspects, vital for the treatment process, and require significant resources to ensure safety. E-prescribing technology is a digital prescription…

  • Antiseizure Medications and Antipsychotic Drugs

    Antiseizure Medications and Antipsychotic Drugs Seizures: Pathophysiology and Best Approaches. Drugs Implemented in Treatment A seizure (also known as an epileptic fit) is a clinical manifestation of a brain abnormality that comes from its excessive electrical activity typical of diseases that bear the collective name of epilepsy. Outwardly, they may manifest themselves in the form…

  • Pramlintide as Anti-Diabetic Drug

    Pramlintide as Anti-Diabetic Drug There are many drugs that can be prescribed to diabetic patients. Symlin, also known by its generic name as pramlintide, is one of the best and well-known analogs of the peptide hormone amylin (Jorsal, Rungby, Knop, & Vilsbøll, 2016). This characteristic makes pramlintide an effective drug for treating patients who have…

  • Rohypnol and Illegal Drugs in Clinical Trials

    Rohypnol and Illegal Drugs in Clinical Trials Rohypnol Rohypnol is a generic drug known as flunitrazepam which contains lorazepam, diazepam, and alprazolam. This type of drug is a strong muscle relaxer, approximately ten times Valium. It is mostly used for the treatment of insomnia, seizures, and anxiety (Oluwole et al., 2020). In addition, it is…

  • Performance Enhancing Drugs Legalization in Sports

    Performance Enhancing Drugs Legalization in Sports Performance Improvement and Drugs Performance enhancing drugs are defined as those substances that are used by athletes in order to improve their performance in sports in which they have engaged. The trend of increased usage of these drugs had resulted in their ban by a number of international organizations…

  • Ilaris(R)-Drug Usage in U.S. and Australia

    Ilaris(R)-Drug Usage in U.S. and Australia Table of Contents Introduction Chemical Name and Formulae Conclusion Bibliography Introduction Ilaris(R) is a drug that has been approved for use in humans by The Pharmaceutical Benefits Scheme (PBS) and The Food and Drug Administration (FDA) both. FDA Is the main administrative body in charge of drug approvals in…

  • Psychotropic Drugs Usage, Effects, Consequences

    Psychotropic Drugs Usage, Effects, Consequences Mental and behavioral disorders constitute a significant proportion of the global burden of disease, yet only a minuscule fraction of those suffering from such conditions can access primary treatment. In developing countries, only a tiny percentage of persons with mental disorders see a doctor, and health care is often unable…

  • Response to a Journal Article on Drug Control Policy

    Response to a Journal Article on Drug Control Policy Table of Contents Introduction Background Discussion of method Analysis Conclusion References Introduction This is a response paper to Philip Palmgreens journal article Effects of the Office of National Drug Control Policys Marijuana Initiative Campaign on High-Sensation-Seeking Adolescents published in the American Journal of Public Health in…